Back to NGNE
MARSHALL WACE, LLP NGNE Position History
Neurogene Inc. • Healthcare
Quarters held
7
Latest value
$4.4M
Q3 2026
Peak value
$4.4M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $1.5M |
| Q2 2024 | $29K |
| Q2 2024 | $1.5M |
| Q3 2024 | $419K |
| Q1 2025 | $206K |
| Q3 2026 | $326K |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 156.8K | — | — |
| Q3 2026 | $326K | 11.7K | — | — |
| Q1 2025 | $206K | 17.6K | — | — |
| Q3 2024 | $419K | 10.0K | — | — |
| Q2 2024 | $1.5M | 40.6K | — | — |
| Q2 2024 | $29K | 800 | — | — |
| Q1 2024 | $1.5M | 30.2K | — | — |
Other funds holding NGNE
$51.9M
$51.7M
$48.6M
$44.4M
$44.1M
$43.5M
$42.8M